Rui Wang

Prof. Rui Wang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JBJing Bai
Jing Bai
JQJianbo Qi
Jianbo Qi
LYLi Yang
Li Yang
ZWZhengtao Wang
Zhengtao Wang
RWRui Wang
Rui Wang
YSYanhong Shi
Yanhong Shi

19 January 2021 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
YMYun-Qiu Miao
Yun-Qiu Miao
MCMing-Shu Chen
Ming-Shu Chen
XZXin Zhou
Xin Zhou
LGLin-Miao Guo
Lin-Miao Guo
JZJing-Jing Zhu
Jing-Jing Zhu
YGYong Gan
Yong Gan

30 July 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
JLJingyi Li
Jingyi Li
YZYaqi Zhang
Yaqi Zhang
MYMiaorong Yu
Miaorong Yu
AWAohua Wang
Aohua Wang
YQYu Qiu
Yu Qiu
YGYong Gan
Yong Gan
Transporters are traditionally considered to transport small molecules rather than large-sized nanoparticles due to their small pores. In this study, we demonstrate that the upregulated intestinal transporter (PCFT), which reaches a maximum of 12.3-fold expression in the intestinal epithelial cells of diabetic rats, mediates the uptake of the folic acid-grafted nanoparticles (FNP). Specifically, the upregulated PCFT could exert its function to mediate the endocytosis of FNP and efficiently stimulate the traverse of FNP across enterocytes by the lysosome-evading pathway, Golgi-targeting pathway and basolateral exocytosis, featuring a high oral insulin bioavailability of 14.4% in the diabetic rats. Conversely, in cells with relatively low PCFT expression, the positive surface charge contributes to the cellular uptake of FNP, and FNP are mainly degraded in the lysosomes. Overall, we emphasize that the upregulated intestinal transporters could direct the uptake of ligand-modified nanoparticles by mediating the endocytosis and intracellular trafficking of ligand-modified nanoparticles via the transporter-mediated pathway. This study may also theoretically provide insightful guidelines for the rational design of transporter-targeted nanoparticles to achieve efficient drug delivery in diverse diseases.

1 June 2020 in Phytochemistry
Verified
Journal Article
Closed access
DZDongdong Zhang
Dongdong Zhang
DRDeqing Ruan
Deqing Ruan
JLJingyi Li
Jingyi Li
ZCZhaoqiang Chen
Zhaoqiang Chen
WZWeiliang Zhu
Weiliang Zhu
RWRui Wang
Rui Wang

7 November 2019 in Molecules
Verified
Journal Article
Open access
PDF file
DZDongdong Zhang
Dongdong Zhang
YSYanhong Shi
Yanhong Shi
JLJingyi Li
Jingyi Li
DRDeqing Ruan
Deqing Ruan
QJQi Jia
Qi Jia
RWRui Wang
Rui Wang
As our ongoing research project on Ban Lan Gen (Isatis tinctoria roots), a total of 23 alkaloids were obtained. Compounds 1 and 2 contain an unusual C–C bond between the 2(1H)-quinolinone moiety and the phenol moiety and between the 2(1H)-quinolinone moiety and the 1H-indole moiety, respectively. Compound 3 possesses an unusual carbon skeleton and its putative biosynthetic pathway was discussed, and Compound 23 was deduced as a new indole alkaloid glycoside. Compounds 4–7 were identified as four new natural products by extensive spectroscopic experiments. Additionally, the anti-inflammatory activity was assessed based on nitric oxide (NO) production using Lipopolysaccharide-stimulated RAW264.7 macrophages. Compounds 9, 15, and 17 showed inhibitory effects with IC50 values of 1.2, 5.0, and 74.4 μM.

1 September 2019 in Fitoterapia
Verified
Journal Article
Closed access
DZDongdong Zhang
Dongdong Zhang
JLJingyi Li
Jingyi Li
DRDeqing Ruan
Deqing Ruan
ZCZhaoqiang Chen
Zhaoqiang Chen
WZWeiliang Zhu
Weiliang Zhu
RWRui Wang
Rui Wang